Targeting Protein Kinase Inhibitors with Traditional Chinese Medicine

Current Drug Targets
Yangyang ZhangXiukun Lin

Abstract

Protein kinases play critical roles in the control of cell growth, proliferation, migration, and angiogenesis, through their catalytic activity. Over the past years, numerous protein kinase inhibitors have been identified and are being successfully used clinically. Traditional Chinese medicine (TCM) represents a large class of bioactive substances, and some of them display anticancer activity via inhibiting protein kinases signal pathway. Some of the TCM have been used to treat tumors clinically in China for many years. The p38mitogen-activated protein kinase (MAPK), phosphoinositide 3-kinase, serine/threonine-specific protein kinases (PI3K/AKT/mTOR), and extracellular signal-regulated kinases (ERK) pathways are considered important signals in cancer cell development. In the present article, the recent progress of TCM that exhibited significant inhibitory activity towards a range of protein kinases is discussed. The clinical efficacy of TCM with inhibitory effects on protein kinases in treating a tumor is also presented. The article also discussed the prospects and problems in the development of anticancer agents with TCM.

References

Mar 10, 2001·Nature·L Chang, M Karin
Dec 6, 2003·Proceedings of the National Academy of Sciences of the United States of America·Valerie I BrownStephan A Grupp
Apr 23, 2004·Trends in Molecular Medicine·James M Olson, Andrew R Hallahan
Jun 10, 2006·The Journal of Biological Chemistry·Padma Kannan-ThulasiramanLeonidas C Platanias
Mar 17, 2007·Journal of Natural Products·Yoichi Nakao, Nobuhiro Fusetani
Aug 19, 2007·Molecular Cancer Therapeutics·James A CrowellJudith R Fay
Jan 26, 2008·Chinese Journal of Integrative Medicine·Ping LuQin-liang Hua
Feb 22, 2008·Current Cancer Drug Targets·P Sapra SharmaR Tyagi
Oct 18, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Rui YangRichard Gorlick
Oct 22, 2008·Oncogene·D N Dhanasekaran, E P Reddy
Jul 25, 2009·Nature Reviews. Cancer·Erwin F Wagner, Angel R Nebreda
Nov 3, 2009·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Chun-Ying XieXi-Sha Wang
Dec 15, 2010·International Journal of Oncology·Bai-Cheng HeBing-Qiang Zhang
Oct 1, 2011·Apoptosis : an International Journal on Programmed Cell Death·Gang ChenYi-Fang Zhao
Nov 24, 2011·Mutation Research·Hanna PiotrowskaMarek Murias
May 24, 2014·Oncology Research·Haizhou LiuXiukun Lin
Jul 30, 2014·World Journal of Gastroenterology : WJG·Masashi Kanai
Jul 30, 2014·Frontiers in Genetics·Fabrizio FerrèManuela Helmer-Citterich
Dec 17, 2014·BMC Complementary and Alternative Medicine·Jian-Hua YinLu-Ming Liu
Oct 17, 2015·European Journal of Drug Metabolism and Pharmacokinetics·Qian ZhaoPei Hu
Jul 20, 2016·International Journal of Molecular Medicine·Xiaoming YuYu Zhao

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis